TransCode Therapeutics Statistics

Total Valuation

RNAZ has a market cap or net worth of $4.72 million. The enterprise value is -$8.11 million.

Market Cap	4.72M
Enterprise Value	-8.11M

Important Dates

The last earnings date was Friday, May 15, 2026, after market close.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

RNAZ has 950,302 shares outstanding. The number of shares has increased by 1,515.08% in one year.

Current Share Class	950,302
Shares Outstanding	950,302
Shares Change (YoY)	+1,515.08%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	7.61%
Float	865,764

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.64
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.11

Current Ratio	3.11
Quick Ratio	2.39
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,591.28

Financial Efficiency

Return on equity (ROE) is -52.14% and return on invested capital (ROIC) is -18.85%.

Return on Equity (ROE)	-52.14%
Return on Assets (ROA)	-17.13%
Return on Invested Capital (ROIC)	-18.85%
Return on Capital Employed (ROCE)	-15.38%
Weighted Average Cost of Capital (WACC)	11.36%
Revenue Per Employee	n/a
Profits Per Employee	-$3.64M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, RNAZ has paid $457,377 in taxes.

Income Tax	457,377
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.12% in the last 52 weeks. The beta is 1.29, so RNAZ's price volatility has been higher than the market average.

Beta (5Y)	1.29
52-Week Price Change	-35.12%
50-Day Moving Average	6.51
200-Day Moving Average	9.02
Relative Strength Index (RSI)	42.08
Average Volume (20 Days)	145,743

Short Selling Information

The latest short interest is 28,142, so 2.96% of the outstanding shares have been sold short.

Short Interest	28,142
Short Previous Month	36,265
Short % of Shares Out	2.96%
Short % of Float	3.25%
Short Ratio (days to cover)	2.39

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.35M
Pretax Income	-39.90M
Net Income	-43.70M
EBITDA	-23.26M
EBIT	-23.35M
Earnings Per Share (EPS)	-$49.89

Full Income Statement

Balance Sheet

The company has $12.84 million in cash and n/a in debt, giving a net cash position of $12.84 million or $13.51 per share.

Cash & Cash Equivalents	12.84M
Total Debt	n/a
Net Cash	12.84M
Net Cash Per Share	$13.51
Equity (Book Value)	144.52M
Book Value Per Share	1.36
Working Capital	11.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.40 million and capital expenditures -$6,660, giving a free cash flow of -$21.40 million.

Operating Cash Flow	-21.40M
Capital Expenditures	-6,660
Depreciation & Amortization	86,939
Net Borrowing	n/a
Free Cash Flow	-21.40M
FCF Per Share	-$22.52

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RNAZ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,515.08%
Shareholder Yield	-1,515.08%
Earnings Yield	-925.18%
FCF Yield	-453.19%

Analyst Forecast

The average price target for RNAZ is $280.00, which is 5,533.80% higher than the current price. The consensus rating is "Buy".

Price Target	$280.00
Price Target Difference	5,533.80%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on May 15, 2025. It was a reverse split with a ratio of 1:28.

Last Split Date	May 15, 2025
Split Type	Reverse
Split Ratio	1:28

Scores

Altman Z-Score	n/a
Piotroski F-Score	1